Detalhe da pesquisa
1.
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature
; 603(7903): 934-941, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130560
2.
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.
Blood Adv
; 8(6): 1474-1486, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295285
3.
αßγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction.
Proc Natl Acad Sci U S A
; 107(45): 19573-8, 2010 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974939
4.
Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma.
J Neuropathol Exp Neurol
; 82(2): 160-168, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592076
5.
Molecular, cellular and functional events in axonal sprouting after stroke.
Exp Neurol
; 287(Pt 3): 384-394, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874223
6.
GDF10 is a signal for axonal sprouting and functional recovery after stroke.
Nat Neurosci
; 18(12): 1737-45, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26502261